{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:36Z","timestamp":1786984296194,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.amjcard.2015.12.030","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T22:17:01Z","timestamp":1451427421000},"page":"952-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy"],"prefix":"10.1016","volume":"117","author":[{"given":"Deepak","family":"Acharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Revilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2328-4590","authenticated-orcid":false,"given":"Taimoor","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charity J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salpy V.","family":"Pamboukian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo Y.","family":"Loyaga-Rendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Tallaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.12.030_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ahj.2007.10.020","article-title":"Characteristics of \u201cStage D\u201d heart failure: Insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM)","volume":"155","author":"Costanzo","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2015.12.030_bib2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research group","volume":"325","author":"Packer","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.12.030_bib3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2015.12.030_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.030_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1053-2498(03)00203-1","article-title":"Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure","volume":"23","author":"Upadya","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.amjcard.2015.12.030_bib6","first-page":"109","article-title":"Intravenous milrinone in treatment of advanced congestive heart failure","volume":"30","author":"Zewail","year":"2003","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.amjcard.2015.12.030_bib7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCHEARTFAILURE.114.001778","article-title":"Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure","volume":"8","author":"Hashim","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2015.12.030_bib8","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1345\/aph.1M357","article-title":"Use of combination therapy with a beta-blocker and milrinone in patients with advanced heart failure","volume":"43","author":"Jennings","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2015.12.030_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/CIRCHEARTFAILURE.114.001528","article-title":"Intravenous home inotropic use is safe in pediatric patients awaiting transplantation","volume":"8","author":"Birnbaum","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2015.12.030_bib10","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1378\/chest.125.4.1198","article-title":"Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study","volume":"125","author":"Nanas","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2015.12.030_bib11","first-page":"57","article-title":"Different responses to inotropic agents after long term B-blockade with either metoprolol or carvedilol in patients with chronic heart failure","volume":"2","author":"Metra","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2015.12.030_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/mhj.2001.117605","article-title":"Carvedilol titration in patients with congestive heart failure receiving inotropic therapy","volume":"142","author":"Kumar","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2015.12.030_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1592\/phco.27.5.697","article-title":"Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone","volume":"27","author":"Earl","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjcard.2015.12.030_bib14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0735-1097(98)00077-1","article-title":"Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure","volume":"31","author":"Shakar","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.12.030_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cardfail.2014.06.004","article-title":"Are peripherally inserted central catheters associated with increased risk of adverse events in status 1B patients awaiting transplantation on continuous intravenous milrinone?","volume":"20","author":"Haglund","year":"2014","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.amjcard.2015.12.030_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.amjmed.2012.04.010","article-title":"Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence","volume":"125","author":"Chopra","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2015.12.030_bib17","first-page":"CD007878","article-title":"Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults","volume":"6","author":"Lai","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjcard.2015.12.030_bib18","series-title":"Preventing Central Line-associated Bloodstream Infections: A Global Challenge, a Global Perspective","year":"2012"},{"key":"10.1016\/j.amjcard.2015.12.030_bib19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1378\/chest.112.5.1298","article-title":"Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes","volume":"112","author":"Harjai","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2015.12.030_bib20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-8703(96)90315-4","article-title":"Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure","volume":"132","author":"Marius-Nunez","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2015.12.030_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cardfail.2004.02.004","article-title":"Comparative costs of home positive inotropic infusion versus in-hospital care in patients awaiting cardiac transplantation","volume":"10","author":"Upadya","year":"2004","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.amjcard.2015.12.030_bib22","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.healun.2003.08.017","article-title":"A\u00a0prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home","volume":"23","author":"Brozena","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.amjcard.2015.12.030_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCHEARTFAILURE.108.839076","article-title":"Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure","volume":"2","author":"Gorodeski","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2015.12.030_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1054\/jcaf.2003.24","article-title":"Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure","volume":"9","author":"Hershberger","year":"2003","journal-title":"J\u00a0Card Fail"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915300758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915300758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T01:57:27Z","timestamp":1617155847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915300758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0002914915300758"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.12.030","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}